Telum Therapeutics
Funding to advance antimicrobial therapy for drug-resistant pneumonia
July 1, 2026Telum Therapeutics, pneumonia
Telum Therapeutics has raised €18m in Series A financing to advance its lead antimicrobial programme into phase 1 clinical development …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
